NEONATAL ABSTINENCE SYNDROME
Clinical trials for NEONATAL ABSTINENCE SYNDROME explained in plain language.
Never miss a new study
Get alerted when new NEONATAL ABSTINENCE SYNDROME trials appear
Sign up with your email to follow new studies for NEONATAL ABSTINENCE SYNDROME, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Ear-Zap device may cut morphine days for Opioid-Dependent newborns
Symptom relief OngoingThis study tested a small device that sends mild electrical pulses to the ear (tAN therapy) in 52 newborns with opioid withdrawal. The goal was to see if it could reduce the number of days the babies needed morphine and shorten their hospital stay. The device was used alongside s…
Matched conditions: NEONATAL ABSTINENCE SYNDROME
Phase: NA • Sponsor: Spark Biomedical, Inc. • Aim: Symptom relief
Last updated May 15, 2026 11:54 UTC
-
AI could help babies born addicted to opioids get better care faster
Knowledge-focused ENROLLING_BY_INVITATIONThis study gathers health data from 100 newborns—80 with neonatal abstinence syndrome (NAS) and 20 healthy—to train an artificial intelligence (AI) system. The AI aims to automatically score NAS symptoms and predict when medication is needed, replacing current subjective methods.…
Matched conditions: NEONATAL ABSTINENCE SYNDROME
Sponsor: Rekovar Inc. • Aim: Knowledge-focused
Last updated May 17, 2026 05:45 UTC
-
Can a smartphone app prepare moms for caring for opioid-exposed newborns?
Knowledge-focused OngoingThis study is testing a mobile app designed to teach pregnant women who are in treatment for opioid use disorder how to care for newborns at risk for Neonatal Abstinence Syndrome (NAS). The app aims to help mothers learn effective caregiving strategies before their baby is born. …
Matched conditions: NEONATAL ABSTINENCE SYNDROME
Phase: NA • Sponsor: Washington State University • Aim: Knowledge-focused
Last updated May 17, 2026 05:32 UTC